Company Directory / research
PrivateFor profitresearchSan Francisco, United States
Mana.bio
Mana.bio is an AI based drug delivery startup, focusing on gene therapy including DNA and RNA-based therapeutics, and vaccines.
- Founded
- 2021 5 years ago
- Staff
- 11-50 band, as listed
- Followers
- - on LinkedIn
- Funding
- $30M as listed, currency not stated
Set against six million companies
Size
11-50 people: larger than 33% of companies with a size listed
Age
5 years old.
Reach
Website ranked #7,979,029 in the world for traffic, about 671 visits a month.
What it does
Biotechnology
Funding, as listed
$30M currency not stated
- Rounds3
- LatestSeed, Oct 2023
- Investors5, 2 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Mana.bio, field by field. Contact details are held but never shown.
The company
- Name
- Mana.bio
- Type
- For profit
- Status
- Private
- Founded
- 2021
- Founders
- Roy Nevo, Yogev Debbi
- Industry
- research
- Categories
- Biotechnology
Where
- City
- San Francisco
- Country
- United States
- Markets
- San Francisco Bay Area, West Coast, Western US
Size and reach
- Staff band
- 11-50
- Web traffic rank
- #7,979,029
- Monthly web visits
- 671
Funding, as listed
- Total
- 29,500,000 (currency not stated)
- Rounds
- 3
- Latest round
- Seed
- Latest round date
- Oct 2023
- Investors
- 5
- Lead investors
- 2
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Mana.bio may be growing as evidenced by the launch of their AI-fueled programmable drug therapy, which indicates product development and potential market expansion. The company's initiative in the biotechnology industry, specifically in gene therapy including DNA and RNA-based therapeutics and vaccines, is a sign of innovation and aligns with the current trends in biotech advancements. The fact that Mana.bio is an Israeli biotech startup and has been featured in a prominent publication like TechCrunch suggests recognition within the industry and could imply investor interest or future funding opportunities.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
research in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.